Chronic stress is epidemic, and it is killing us. We know that and strive to become healthier. For some people that can be ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...

If you or a loved one has been diagnosed with schizophrenia, here’s what to know about the causes of cognitive symptoms, their health effects, and how to manage them. “These difficulties could ...

Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, discusses the bidirectional relationship between schizophrenia and ...

Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Schizophrenia cases associated with problematic weed use have skyrocketed in the wake of Canada's legalization of marijuana, a new study says.

OPC-4392 was shown to be effective against negative symptoms and showed no propensity to induce extrapyramidal symptoms in individuals with schizophrenia ... as at novel serotonin receptor ...

Here, we present a brief review of some insights we have gained into the dimerization of dopamine and serotonin receptors. We have demonstrated that agonist-regulated trafficking is identical for ...

The three phases of schizophrenia are the prodromal, active, and residual phases. Symptoms of schizophrenia can depend on the phase. Early symptoms of schizophrenia may be similar to other conditions.

They also include 5-hydroxytryptophan, which can help to boost serotonin, the neurotransmitter in the brain that affects a person’s mood. Learn more about herbs and supplements for depression.

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers at the University of Barcelona have identified a deficit in contrast perception in people ...